KINGS POINT CAPITAL MANAGEMENT - CLEVELAND BIOLABS INC ownership

CLEVELAND BIOLABS INC's ticker is CBLI and the CUSIP is 185860103. A total of 44 filers reported holding CLEVELAND BIOLABS INC in Q3 2013. The put-call ratio across all filers is 0.07 and the average weighting 0.0%.

Quarter-by-quarter ownership
KINGS POINT CAPITAL MANAGEMENT ownership history of CLEVELAND BIOLABS INC
ValueSharesWeighting
Q4 2013$12,000
-25.0%
10,0000.0%0.00%
-33.3%
Q3 2013$16,0000.0%10,0000.0%0.01%
-14.3%
Q2 2013$16,00010,0000.01%
Other shareholders
CLEVELAND BIOLABS INC shareholders Q3 2013
NameSharesValueWeighting ↓
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 697,300$1,102,0000.26%
GOODNOW INVESTMENT GROUP, LLC 601,889$951,0000.17%
MACROVIEW INVESTMENT MANAGEMENT LLC 38,000$60,0000.06%
BHR Capital LLC 300,000$474,0000.05%
LADENBURG THALMANN FINANCIAL SERVICES INC. 746,200$1,172,0000.04%
PRELUDE CAPITAL MANAGEMENT, LLC 67,200$106,0000.02%
Van Cleef Asset Management,Inc 20,000$32,0000.02%
RICE HALL JAMES & ASSOCIATES, LLC 69,981$111,0000.01%
KINGS POINT CAPITAL MANAGEMENT 10,000$16,0000.01%
TAURUS ASSET MANAGEMENT, LLC 15,000$24,0000.01%
View complete list of CLEVELAND BIOLABS INC shareholders